Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
PR Newswire (May 13, 2013)
-
PR Newswire (May 10, 2013)
-
PR Newswire (May 10, 2013)
-
PR Newswire (May 3, 2013)
-
PR Newswire (Apr 25, 2013)
-
PR Newswire (Mar 1, 2013)
-
PR Newswire (Feb 25, 2013)
-
PR Newswire (Feb 18, 2013)
-
PR Newswire (Feb 6, 2013)
-
PR Newswire (Jan 3, 2013)
-
Clinical Trial Data Spikes Lexicon Pharma SharesBrian L. Wilson • Fri, Oct 12, 2012
-
Top 5 Stocks With Insider Buys Filed During The Week Ending October 26Markus Aarnio • Sun, Oct 28, 2012
-
7 Small Cap Stocks Holding Low Debt Ratios And Positive Analyst RatingsZetaKap • Tue, Aug 21, 2012
-
Lexicon Pharmaceuticals, Inc. Q1 2010 Earnings Call TranscriptThu, May 13, 2010
-
Lexicon Pharmaceuticals, Inc. Q4 2009 Earnings Call TranscriptTue, Feb 23, 2010
-
PR Newswire (May 13, 2013)
-
PR Newswire (May 10, 2013)
-
PR Newswire (May 10, 2013)
-
PR Newswire (May 3, 2013)
-
PR Newswire (Apr 25, 2013)
-
PR Newswire (Mar 1, 2013)
-
PR Newswire (Feb 25, 2013)
-
PR Newswire (Feb 18, 2013)
-
PR Newswire (Feb 6, 2013)
-
PR Newswire (Jan 3, 2013)
-
PR Newswire (Dec 17, 2012)
-
PR Newswire (Nov 20, 2012)
-
PR Newswire (Nov 12, 2012)
-
PR Newswire (Nov 6, 2012)
-
PR Newswire (Nov 6, 2012)
-
PR Newswire (Oct 31, 2012)
-
PR Newswire (Oct 18, 2012)
-
PR Newswire (Oct 17, 2012)
-
at MarketWatch.com (Oct 12, 2012)
LXRX vs. ETF Alternatives
Company Description
Lexicon Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. We have used our proprietary gene knockout technologies and an integrated platform of advanced medical technologies to systematically study the... More





